The human gut mycobiome: Pitfalls and potentials-a mycologist's perspective

Mycologia

Volumn 107, Issue 6, 2015, Pages 1057-1073

  Suhr, Mallory J ^a   Hallen Adams, Heather E ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

Candida; Human health; Microbiome; Nextgeneration sequencing

Indexed keywords

BACTERIUM; COLONIZATION; DIGESTIVE SYSTEM; EUKARYOTE; NICHE; PUBLIC HEALTH; RARE SPECIES; YEAST;

CANDIDA; DIPODASCACEAE; EUKARYOTA; FUNGI; MALASSEZIA; SACCHAROMYCES;

CLASSIFICATION; FUNGUS; GASTROINTESTINAL TRACT; GENETICS; HUMAN; INTESTINE FLORA; ISOLATION AND PURIFICATION; MICROBIOLOGY;

FUNGI; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS;

EID: 84958241663     PISSN: 00275514     EISSN: 15572536     Source Type: Journal    
DOI: 10.3852/15-147     Document Type: Article

References (148)

1. Adam B, Baillie GS, Douglas LJ. 2002. Mixed species biofilms of Candida albicans and Staphylococcus epidermidis. J Med Microbiol 51:344-349, doi:10.1099/0022-1317-51-4-344
2. Adams F. 1939. The genuine works of Hippocrates, Francis Adams translations epidemics, Book 3 Circa 460-377, BC. Baltimore, Maryland: Williams & Wilkins
3. Agirbasli H, Ozcan SA, Gedikoğlu G. 2005. Fecal fungal flora of pediatric healthy volunteers and immunosuppressed patients. Mycopathologia 159:515-520, doi:10.1007/s11046-005-3451-2
4. Anderson HW. 1917. Yeast-like fungi of the human intestinal tract. J Infect Dis 21:341-354, doi:10.1093/infdis/21.4.341
5. Angebault C, Djossou F, Abélanet S, Permal E, Ben Soltana M, Diancourt L, Bouchier C, Woerther PL, Catzeflis F, Andremont A, d'Enfert C, Bougnoux ME. 2013. Candida albicans is not always the preferential yeast colonizing humans: a study in Wayampi Amerindians. J Infect Dis 208:1705-1716, doi:10.1093/infdis/jit389
6. Arendorf TM, Walker DM. 1979. Oral candidal populations in health and disease. Br Dent J 147:267-272, doi:10. 1038/sj.bdj.4804344
7. Ashford BK. 1915. Relation of the genus "Monila" to certain fermentative conditions of the intestinal tract in Porto Rico. JAMA 64:1893-1896.
8. Beck JM, Young VB, Huffnagle GB. 2012. The microbiome of the lung. Transl Res 160:258-266, doi:10.1016/j. trsl.2012.02.005
9. Benno Y, Sawada K, Mitsuoka T. 1984. The intestinal microflora of infants: composition of fecal flora in breast-fed and bottle-fed infants. Microbiol Immunol 28:975-986, doi:10.1111/j.1348-0421.1984.tb00754.x
10. Biasoli MS, Tosello ME, Magaró HM. 2002. Adherence of Candida strains isolated from the human gastrointestinal tract. Mycoses 45:465-469, doi:10.1046/j.1439-0507.2002. 00793.x
11. Bik EM, Eckburg PB, Gill SR, Nelson KE, Purdom EA, Francois F, Perez-Perez G, Blaser MJ, Relman DA. 2006. Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci USA 103:732-737, doi:10.1073/pnas.0506655103
12. Bliss JM, Basavegowda KP, Watson WJ, Sheikh AU, Ryan RM. 2008. Vertical and horizontal transmission of Candida albicans in very low birth weight infants using DNA fingerprinting techniques. Pediatr Infect Dis J 27:231-235, doi:10.1097/INF.0b013e31815bb69d
13. Brabander JOW, Blank F, Butas CA. 1957. Intestinal moniliasis in adults. Can Med Assoc J 77:478-483.
14. Bravo MV, Bunout D, Leiva L, de la Maza MP, Barrera G, de la Maza J, Hirsch S. 2008. Effect of probiotic Saccharomyces boulardii on prevention of antibioticassociated diarrhea in adult outpatients with amoxicillin treatment. Rev Med Chil 136:981-988, doi:/S0034-98872008000800004
15. Buffo J, Herman MA, Soll DR. 1984. A characterization of pH-regulated dimorphism in Candida albicans. Mycopathologia 85:21-30, doi:10.1007/BF00436698
16. Cano RJ, Rivera-Perez J, Toranzos GA, Santiago-Rodriguez TM, Narganes-Storde YM, Chanlatte-Baik L, García-Roldán E, Bunkley-Williams L, Massey SE. 2014. Paleomicrobiology: revealing fecal microbiomes of ancient indigenous cultures. PLoS One 9:e106833, doi:10.1371/journal.pone.0106833
17. Carraro L, Maifreni M, Bartolomeoli I, Martino ME, Novelli E, Frigo F, Marino M, Cardazzo B. 2011. Comparison of culture-dependent and independent methods for bacterial community monitoring during Montasio cheese manufacturing. Res Microbiol 162:231-239, doi:10.1016/j.resmic.2011.01.002
18. Chen Y, Chen Z, Guo R, Chen N, Lu H, Huang S, Wang J, Li L. 2011. Correlation between gastrointestinal fungi and varying degrees of chronic hepatitis B virus infection. Diagn Microbiol Infect Dis 70:492-498, doi:10.1016/j. diagmicrobio.2010.04.005
19. Clemente JC, Ursell LK, Parfrey LW, Knight R. 2012. The impact of the gut microbiota on human health: an integrative review. Cell 148:1258-1270, doi:10.1016/j.cell. 2012.01.035
20. Cohen R, Roth FJ, Delgado E, Ahearn DG, Kalser MH. 1969. Fungal flora of the normal human small and large intestine. N Engl J Med 280:638-641, doi:10.1056/NEJM196903202801204
21. Conti HR, Shen F, Nayyar N, Stocum E, Sun JN, Lindemann MJ, Ho AW, Hai JH, Yu JJ, Jung JW, Filler SG, Masso-Welch P, Edgerton M, Gaffen SL. 2009. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 206:299-311, doi:10.1084/jem.20081463
22. Cui L, Morris A, Ghedin E. 2013. The human mycobiome in health and disease. Genome Med 5:63, doi:10.1186/gm467
23. Dagenais TRT, Keller NP. 2009. Pathogenesis of Aspergillus fumigatus in invasive aspergillosis. Clin Microbiol Rev 22:447-465, doi:10.1128/CMR.00055-08
24. Das S, Dash HR, Mangwani N, Chakraborty J, Kumari S. 2014. Understanding molecular identification and polyphasic taxonomic approaches for genetic relatedness and phylogenetic relationships of microorganisms. J Microbiol Methods 103:80-100, doi:10.1016/j.mimet.2014.05.013
25. David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach MA, Biddinger SB, Dutton RJ, Turnbaugh PJ. 2014. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505:559-563, doi:10.1038/nature12820
26. De Luca A, Zelante T, D'Angelo C, Zagarella S, Fallarino F, Spreca A, Iannitti RG, Bonifazi P, Renauld JC, Bistoni F, Puccetti P, Romain L. 2010. IL-22 defines a novel immune pathway of antifungal resistance. Mucosal Immunol 3:361-373, doi:10.1038/mi.2010.22
27. Di Giulio DB, Romero R, Amogan HP, Kusanovic JP, Bik EM, Gotsch F, Kim CJ, Erez O, Edwin S, Relman DA. 2008. Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and culture-based investigation. PLoS One 3:e3056, doi:10.1371/journal.pone.0003056
28. Dollive S, Chen YY, Grunberg S, Bittinger K, Hoffmann C, Vandier L, CuffC, Lewis JD, Wu GD, Bushman FD. 2013. Fungi of the murine gut: episodic variation and proliferation during antibiotic treatment. PLoS One 8: e71806, doi:10.1371/journal.pone.0071806
29. Dollive S, Peterfreund GL, Sherrill-Mix S, Bittinger K, Sinha R, Hoffmann C, Nabel CS, Hill DA, Artis D, Bachman MA, Custers-Allen R, Grunberg S, Wu GD, Lewis JD, Bushman FD. 2012. A tool kit for quantifying eukaryotic rRNA gene sequences from human microbiome samples. Genome Biol 13:R60, doi:10.1186/gb-2012-13-7-r60
30. Drell T, Lillsaar T, Tummeleht L, Simm J, Aaspõllu A, Väin E, Saarma I, Salumets A, Donders GG, Metsis M. 2013. Characterization of the vaginal micro-and mycobiome in asymptomatic reproductive-age Estonian women. PLoS One 8:e54379, doi:10.1371/journal.pone.0054379
31. Ellis-Pegler RB, Crabtree C, Lambert HP. 1975. The fecal flora of children in the United Kingdom. J Hyg (Lond) 75:135-142, doi:10.1017/S002217240004715X
32. Erb Downward JR, Falkowski NR, Mason KL, Muraglia R, Huffnagle GB. 2013. Modulation of post-antibiotic bacterial community reassembly and host response by Candida albicans. Sci Rep 3:2191, doi:10.1038/srep02191
33. Ferwerda B, Ferwerda G, Plantinga TS, Willment JA, van Spriel AB, Venselaar H, Elbers CC, Johnson MD, Cambi A, Huysamen C, Jacobs L, Jansen T, Verheijen K, MasthoffL, Morré SA, Vriend G, Williams DL, Perfect JR, Joosten LA, Wijmenga C, van der Meer JW, Adema GJ, Kullberg BJ, Brown GD, Netea MG. 2009. Human dectin-1 deficiency and mucocutaneous fungal infections. N Engl J Med 361:1760-1767, doi:10.1056/NEJMoa0901053
34. Findley K, Oh J, Yang J, Conlan S, Deming C, Meyer JA, Schoenfeld D, Nomicos E, Park M, NIH Intramural Sequencing Center Comparative Sequencing Program, Kong HH, Segre JA. 2013. Topographic diversity of fungal and bacterial communities in human skin. Nature 498:367-370, doi:10.1038/nature12171
35. Finegold SM, Attebery HR, Sutter VL. 1974. Effect of diet on human fecal flora: comparison of Japanese and American diets. Am J Clin Nutr 27:1456-1469.
36. Finegold SM, Sutter VL, Sugihara PT, Elder HA, Lehmann SM, Phillips RL. 1977. Fecal microbial flora in Seventh Day Adventist populations and control subjects. Am J Clin Nutr 30:1781-1792.
37. Fleming A. 1929. On the antibacterial action of cultures of a Penicillium, with special reference to their use in the isolation of B influenza. Br J Exp Path 10:226-236.
38. Ghannoum MA, Jurevic RJ, Mukherjee PK, Cui F, Sikaroodi M, Naqvi A, Gillevet PM. 2010. Characterization of the oral fungal microbiome (mycobiome) in healthy individuals. PLoS Pathog 6:e1000713, doi:10.1371/journal. ppat.1000713
39. Giri S, Kindo AJ, Rao S, Kumar AR. 2013. Unusual causes of fungal rhinosinusitis: a study from a tertiary care center in south India. Indian J Med Microbiol 31:379-384, doi:10.4103/0255-0857.118901
40. Gosiewski T, Salamon D, Szopa M, Sroka A, Malecki MT, Bulanda M. 2014. Quantitative evaluation of fungi of the genus Candida in feces of adult patients with type 1 and 2 diabetes-a pilot study. Gut Pathog 6:43, doi:10.1186/s13099-014-0043-z.
41. Gouba N, Raoult D, Drancourt M. 2013. Plant and fungal diversity in gut microbiota as revealed by molecular and culture investigations. PLoS One 8:e59474, doi:10.1371/journal.pone.0059474
42. Gouba N, Raoult D, Drancourt M. 2014a. Gut microeukaryotes during anorexia nervosa: a case report. BMC Res Notes 7:33, doi:10.1186/1756-0500-7-33
43. Gouba N, Raoult D, Drancourt M. 2014b. Eukaryote culturomics of the gut reveals new species. PLoS One 9:e106994, doi:10.1371/journal.pone.0106994
44. Groll AH, Shah PM, Mentzel C, Schneider M, Just-Nuebling G, Huebner K. 1996. Trends in postmortem epidemiology of invasive fungal infections at a university hospital. J Infect 33:23-32, doi:10.1016/S0163-4453(96)92700-0
45. Gupta AK, Batra R, Bluhm R, Boekhout T, Dawson TL Jr. 2004. Skin diseases associated with Malassezia species. J Am Acad Dermatol 51:785-798, doi:10.1016/j.jaad. 2003.12.034
46. Guslandi M, Giollo P, Testoni PA. 2003. A pilot trial of Saccharomyces boulardii in ulcerative colitis. Eur J Gastroenterol Hepatol 15:697-698, doi:10.1097/01.meg. 0000059138.68845.06
47. Guslandi M, Mezzi G, Sorghi M, Testoni PA. 2000. Saccharomyces boulardii in maintenance treatment of Crohn's disease. Dig Dis Sci 45:1462-1464, doi:10.1023/A: 1005588911207
48. Hallen-Adams HE, Kachman SD, Kim J, Legge RM, Martínez I. 2015. Fungi inhabiting the healthy human gastrointestinal tract: a diverse and dynamic community. Fungal Ecol 15:9-17, doi:10.1016/j.funeco.2015.01.006
49. Hamad I, Sokhna C, Raoult D, Bittar F. 2012. Molecular detection of eukaryotes in a single human stool sample from Senegal. PLoS One 7:e40888, doi:10.1371/journal. pone.0040888
50. Havlickova B, Czaika VA, Friedrich M. 2008. Epidemiological trends in skin mycoses worldwide. Mycoses 51(Suppl 4):2-15, doi:10.1111/j.1439-0507.2008.01606.x
51. Hoffmann C, Dollive S, Grunberg S, Chen J, Li H, Wu GD, Lewis JD, Bushman FD. 2013. Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents. PLoS One 8:e66019, doi:10.1371/journal.pone.0066019
52. Hogan DA, Vik A, Kolter RA. 2004. A Pseudomonas aeruginosa quorum-sensing molecule influences Candida albicans morphology. Mol Microbiol 54:1212-1223, doi:10. 1111/j.1365-2958.2004.04349.x
53. Huffnagle GH, Noverr MC. 2013. The emerging world of the fungal microbiome. Trends Microbiol 21:334-341, doi:10.1016/j.tim.2013.04.002
54. Human Microbiome Project Consortium. 2012. Structure, function and diversity of the healthy human microbiome. Nature 486:207-214, doi:10.1038/nature11234
55. Ianiro G, Bruno G, Lopetuso L, Beghella FB, Laterza L, D'Aversa F, Gigante G, Cammarota G, Gasbarrini A. 2014. Role of yeasts in healthy and impaired gut microbiota: the gut mycome. Curr Pharm Des 20:4565-4569, doi:10.2174/13816128113196660723
56. Iliev ID, Funari VA, Taylor KD, Nguyen Q, Reyes CN, Strom SP, Brown J, Becker CA, Fleshner PR, Dubinsky M, Rotter JI, Wang HL, McGovern DP, Brown GD, Underhill DM. 2012. Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis. Science 336:1314-1317, doi:10.1126/science.1221789
57. Iliev ID, Underhill DM. 2013. Striking a balance: fungal commensalism vs. pathogenesis. Curr Opin Microbiol 16:1-8, doi:10.1016/j.mib.2013.05.004
58. Jawhara S, Poulain D. 2007. Saccharomyces boulardii decreases inflammation and intestinal colonization by Candida albicans in a mouse model of chemically induced colitis. Med Mycol 45:691-700, doi:10.1080/13693780701523013
59. Jobst D, Kraft K. 2006. Candida species in stool, symptoms and complaints in general practice-a cross-sectional study of 308 outpatients. Mycoses 49:415-420, doi:10.1111/j.1439-0507.2006.01244.x
60. Kagami S, Rizzo HL, Kurtz SE, Miller LS, Blauvelt A. 2010. IL-23 and IL-17a, but not IL-12 and IL-22, are required for optimal skin host defense against Candia albicans. J Immunol 185:5453-5462, doi:10.4049/jimmunol.1001153
61. Kazan E. Maertens J, Herbrecht R. Weisser M, Gachot B, VekhoffA, Caillot D, Raffoux E, Fagot T, Reman O, Isnard F, Thiebaut A, Bretagne S, Cordonnier C. 2011. A retrospective series of gut aspergillosis in haematology patients. Clin Microbiol Infect 17:588-594, doi:10.1111/j.1469-0691.2010.03310.x
62. Kennedy MJ, Volz PA. 1985. Ecology of Candida albicans gut colonization: inhibition of Candida adhesion, colonization and dissemination from the gastrointestinal tract by bacterial antagonism. Infect Immun 49:654-663.
63. Khatib R, Riederer KM, Ramanathan J, Baran J Jr. 2001. Fecal fungal flora in healthy volunteers and inpatients. Mycoses 44:151-156, doi:10.1046/j.1439-0507.2001. 00639.x
64. Koh AY. 2013. Murine models of Candida gastrointestinal colonization and dissemination. Eukaryot Cell 12:1416-1422, doi:10.1128/EC.00196-13
65. Kohlbrugge JHF. 1901. Die ätiologie der Aphthae tropicae. Archiv für Schiffs-und Tropenhygiene 5:394.
66. Ksiadzyna D, Semianow-Wejchert J, Nawrot U, Wlodarczyk K, Paradowski L. 2009. Serum concentration of interleukin 10, anti-mannan Candida antibodies and the fungal colonization of the gastrointestinal tract in patients with ulcerative colitis. Adv Med Sci 54:170-176, doi:10. 2478/v10039-009-0023-6
67. Kühbacher T, Ott SJ, Helwig U, Mimura T, Rizzello F, Kleesen B, Gionchetti P, Blaut M, Campieri M, Fölsch UR, Kamm MA, Schreiber S. 2006. Bacterial and fungal microbiota in relation to probiotic therapy (VSL 3) in pouchitis. Gut 55:833-841, doi:10.1136/gut.2005. 078303
68. Langenbeck B. 1842. Froriep's Neue Notizen 12:145.
69. Langeron M, Guerra P. 1938. Nouvelles recherches de zymologie médicale. Annal Parasitol Humaine Comparée 16:481-525.
70. LaTuga MS, Ellis JC, Cotton CM, Goldberg RN, Wynn JL, Jackson RB, Seed PC. 2011. Beyond bacteria: a study of the enteric microbial consortium in extremely low birth weight infants. PLoS One 6:e27858, doi:10.1371/journal.pone.0027858
71. Le Dantec A. 1908. Présence d'une levure dans le sprue. Comptes rendus des séances de la Soc biol 64: 1066-1068.
72. Levine HB, Cobet AB. 1970. The tektite-I dive mycological aspects. Arch Env Health 20:500-505, doi:10.1080/00039896.1970.10665629
73. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. 2006. Microbial ecology: human gut microbes associated with obesity. Nature 444:1022-1023, doi:10.1038/4441022a
74. Li E, Hussein H, Todiwala A, Kirby R. 2014. Primary gut aspergillosis in a patient with acute myeloid leukaemia: the importance of early suspicion and definitive treatment. BJM Case Rep doi:10.1136/bcr-2013-202316
75. Li Q, Wang C, Tang C, He Q, Li N, Li J. 2014. Dysbiosis of gut fungal microbiota is associated with mucosal inflammation in Crohn's disease. J Clin Gastroenterol 48:513-523, doi:10.1097/MCG.0000000000000035
76. Li Q, Wang C, Zhang Q, Tang C, Li N, Ruan B, Li J. 2012. Use of 18S ribosomal DNA polymerase chain reactiondenaturing gradient gel electrophoresis to study composition of fungal community in two patients with intestinal transplants. Hum Pathol 43:1273-1281, doi:10.1016/j.humpath.2011.09.017
77. Little AEF, Robinson CJ, Peterson SB, Raffa KF, Handelsman J. 2008. Rules of engagement: interspecies interactions that regulate microbial communities. Ann Rev Microbiol 62:375-401, doi:10.1146/annurev.micro.030608. 101423
78. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. 2012. Diversity, stability and resilience of the human gut microbiota. Nature 489:220-230, doi:10.1038/nature11550
79. Lupetti A, Tavanti A, Davini P, Ghelardi E, Corsini V, Merusi I, Boldrini A, Campa M, Senesi S. 2002. Horizontal transmission of Candida parapsilosis candidemia in a neonatal intensive care unit. J Clin Microbiol 40:2362-2369, doi:10.1128/JCM.40.7.2363-2369.2002
80. Mackie RI, Sghir A, Gaskins HR. 1999. Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutr 69:1035s-1045s.
81. Macura AB, Witalis J. 2010. Fungi isolated from the stool in patients with gastrointestinal disorders in 2005-2009. Przegl Epidemiol 64:313-317.
82. Martin DS, Jones CP. 1940. Further studies on the practical classification of the Monilias. J Bacteriol 39:609-630.
83. Martin DS, Jones CP, Yao KF, Lee LE. 1937. A practical classification of the Monilias. J Bacteriol 34:99-129.
84. Martinsen TC, Bergh K, Waldum HL. 2005. Gastric juice: a barrier against infectious diseases. Basic Clin Pharmacol Toxicol 96:94-102, doi:10.1111/j.1742-7843.2005. pto960202.x
85. Mason KL, Erb Downward JR, Falkowski NR, Young VB, Kao JY, Huffnagle GB. 2012a. Interplay between the gastric bacterial microbiota and Candida albicans during postantibiotic recolonization and gastritis. Infect Immun 80:150-158, doi:10.1128/IAI.05162-11
86. Mason KL, Erb Downward JR, Mason KD, Falkowski NR, Eaton KA, Kao JY, Young VB, Huffnagle GB. 2012b. Candida albicans and bacterial microbiota interactions in the cecum during recolonization following broad-spectrum antibiotic therapy. Infect Immun 80:3371-3380, doi:10.1128/IAI. 00449-12
87. Mayer FL, Wilson D, Hube B. 2013. Candida albicans pathogenicity mechanisms. Virulence 4:119-128, doi:10. 4161/viru.22913
88. McFarland LV. 2007. Meta-analysis of probiotics for the prevention of traveler's diarrhea. Travel Med Infect Dis 5:97-105, doi:10.1097/01.mcg.0000225546.34374.6d
89. McNeil MM, Nash SL, Hajjeh RA, Phelan MA, Conn LA, Plikaytis BD, Warnock DW. 2001. Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997. Clin Infect Dis 33:641-647, doi:10.1086/322606
90. McNeill J, Barrier FR, Buck WR, Demoulin V, Greuter W, Hawksworth DL, Herendeen PS, Knapp S, Marhold K, Prado J, Prud'Homme van Reine WF, Smith GF, Wiersems JH, Turland NJ. 2011. International code of nomenclature for algae, fungi and plants (Melbourne Code). Koenigstein, Germany: Koeltz Scientific Books. 240 p.
91. Moore D, Robson GD, Trinci APJ. 2011. Fungi as pathogens of animals. In: 21st century guidebook to fungi. New York: Cambridge University Press. p 411-448.
92. Moran G, Coleman D, Sullivan D. 2012. An introduction to the medically important Candida species. In: Calderon RA, Clancy CJ, eds. Candida and candidiasis. 2nd ed. Washington, DC: ASM Press. p 11-25.
93. Nam YD, Chang HW, Kim KH, Roh SW, Kim MS, Jung MJ, Lee SW, Kim JY, Yoon JH, Bae JW. 2008. Bacterial, archaeal and eukaryal diversity in the intestines of Korean people. J Microbiol 46:491-501, doi:10.1007/s12275-008-0199-7
94. Nguyen NH, Suh SO, Marshall CJ, Blackwell M. 2006. Morphological and ecological similarities: wood-boring beetles associated with novel xylose-fermenting yeasts, Spathospora passalidarum gen. sp. nov. and Candida jeffriesii sp. nov. Mycol Res 110:1232-1241, doi:10.1016/j. mycres.2006.07.002
95. NIH HMP Working Group, Peterson J, Garges S, Giovanni M, McInnes P, Wang L, Schloss JA, Bonazzi V, McEwen JE, Wetterstrand KA, Deal C, Baker CC, Di Francesco V, Howcroft TK, Karp RW, Lunsford RD, Wellington CR, Belachew T, Wright M, Giblin C, David H, Mills M, Salomon R, Mullins C, Akolkar B, Begg L, Davis C, Grandison L, Humble M, Khalsa J, Little AR, Peavy H, Pontzer C, Portnoy M, Sayre MH, Starke-Reed P, Zakhari S, Read J, Watson B, Guyer M. 2009. The NIH human microbiome project. Genome Res 19:2317-2323, doi:10.1101/gr.096651.109
96. Nocker A, Burr M, Camper AK. 2007. Genotypic microbial community profiling: a critical technical review. Microb Ecol 54:276-289, doi:10.1007/s00248-006-9199-5
97. Noverr MC, Huffnagle GB. 2004a. Regulation of Candida albicans morphogenesis by fatty acid metabolites. Infect Immun 72:6206-6210, doi:10.1128/IAI.72.11. 6206-6210. 2004
98. Nucci M, Anaissie E. 2001. Revisiting the source of candidemia: skin or gut? Clin Infect Dis 33:1959-1967, doi:10.1086/323759
99. Nucci M, Colombo A. 2002. Risk factors for breakthrough candidemia. Eur J Clin Microbiol Infect Dis 21:209-211, doi:10.1007/s10096-002-0697-1
100. Ott SJ, Kühbacher T, Musfeldt M, Rosenstiel P, Hellmig S, Rehman A, Drews O, Weichert W, Timmis KN, Schreiber S. 2008. Fungi and inflammatory bowel diseases: alterations of composition and diversity. Scand J Gastroenterol 43:831-841, doi:10.1080/00365520801935434
101. Pandey PK, Siddharth J, Verma P, Bavdekar A, Patole MS, Shouche YS. 2012. Molecular typing of fecal eukaryotic microbiota of human infants and their respective mothers. J Biosci 37:221-226, doi:10.1007/s12038-012-9197-3
102. Peleg AY, Hogan DA, Mylonakis E. 2010. Medically important bacterial-fungal interactions. Nat Rev Microbiol 8:340-349, doi:10.1038/nrmicro2313
103. Peleg AY, Tampakakis E, Fuchs BB, Eliopoulos GM, Moellering RC Jr, Mylonakis E. 2008. Prokaryote-eukaryote interactions identified by using Caenorhabditis elegans. Proc Natl Acad Sci USA 105:14585-14590, doi:10.1073/pnas.0805048105
104. Porter TM, Golding GB. 2012. Factors that affect large subunit ribosomal DNA amplicon sequencing studies of fungal communities: classification method, primer choice and error. PLoS One 7:e35749, doi:10.1371/journal. pone.0035749
105. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, Mende DR, Li J, Xu J, Li S, Li D, Cao J, Wang B, Liang H, Zheng H, Xie Y, Tap J, Lepage P, BertalanM, Batto JM, Hansen T, Le Pasiler D, Linneberg A, Nielsen HB, Pelletier E, Renault P, Sicheritz-Ponten T, Turner K, Zhu H, Yu C, Li S, Jian M, Zhou Y, Li Y, Zhang X, Li S, Qin N, Yang H, Wang J, Brunak S, Doré J Guarner F, Kristiansen K, Pedersen O, Parkhill J, Weissenbach J, MetaHIT Consortium, Bork P, Ehrlich SD, Wang J. 2010. A human gut microbial gene catalog established by metagenomic sequencing. Nature 464:59-65, doi:10.1038/nature08821
106. Rajilic-Stojanovic M, Smidt H, de Vos WM. 2007. Diversity of the human gastrointestinal tract microbiota revisited. Environ Microbiol 9:2125-2136, doi:10.1111/j.1462-2920.2007.01369.x
107. Rodríguez-Martínez JM, Pascual A. 2006. Antimicrobial resistance in bacterial biofilms. Rev Med Microbiol 17:65-75, doi:10.1016/j.ijantimicag.2009.12.011
108. Rosenbach A, Dignard D, Pierce JV, Whiteway M, Kumamoto CA. 2010. Adaptations of Candida albicans for growth in the mammalian intestinal tract. Eukaryot Cell 9:1075-1086, doi:10.1128/EC.00034-10
109. Saijo S, Fujikado N, Furuta T, Chung SH, Kotaki H, Seki K, Sudo K, Akira S, Adachi Y, Ohno N, Kinjo T, Nakamura K, Kawakami K, Iwakura Y. 2007. Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans. Nat Immunol 8:39-46, doi:10.1038/ni1425
110. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Ehrlich HA, Arnheim N. 1985. Enzymatic amplification of bglobin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230:1350-1354, doi:10.1126/science.2999980
111. Saiman L, Ludington E, Dawson JD, Patterson JE, Rangel-Fraustro S, Wiblin RT, Blumberg HM, Pfaller M, Rinaldi M, Edwards JE, Wenzel RP, Jarvis W, National Epidemiology of Mycoses Study Group. 2001. Risk factors for Candida species colonization of neonatal intensive care unit patients. Pediatr Infect Dis J 20:1119-1124, doi:10.1097/00006454-200112000-00005
112. Samonis G, Gikas A, Anaissie EJ, Vrenzos G, Maraki S, Tselentis Y, Bodey GP. 1993. Prospective evaluation of effects of broad-spectrum antibiotics on gastrointestinal yeast colonization of humans. Antimicrob Agents Chemother 37:51-53, doi:10.1128/AAC.37.1.51
113. Savage DC. 1977. Microbial ecology of the gastrointestinal tract. Ann Rev Microbiol 3:107-133, doi:10.1146/annurev.mi.31.100177.000543
114. Scanlan PD, Marchesi JR. 2008. Micro-eukaryotic diversity of the human distal gut microbiota: qualitative assessment using culture-dependent and independent analysis of feces. ISME J 2:1183-1193, doi:10.1038/ismej.2008.76
115. Schoch CL, Seifert KA, Huhndorf S, Robert V, Spouge JL, Levesque CA, Chen W, Fungal Barcoding Consortium. 2012. Nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for fungi. Proc Natl Acad Sci USA 109:6241-6246, doi:10.1073/pnas.1117018109
116. Schulze J, Sonnenborn U. 2009. Yeasts in the gut: from commensals to infectious agents. Dtsch ärztebl Int 106:837-842, doi:10.3238/arztebl.2009.0837
117. Seebacher C. 1996. Mycophobia-a new disease? Mycoses 39 (Suppl 1):30-32, doi:10.1111/j.1439-0507.1996.tb00500.x.
118. Sobel JD. 2007. Vulvovaginal candidosis. Lancet 369:1961-1971, doi:10.1016/S0140-6736(07)60917-9.
119. Sogin ML, Morrison HG, Huber JA, Welch DM, Huse SM, Neal PR, Arrieta JM, Herndl GJ. 2006. Microbial diversity in the deep sea and the underexplored "rare biosphere". Proc Natl Acad Sci USA 103:12115-12120, doi:10.1073/pnas.0605127103
120. Soyucen E, Gulcan A, Aktuglu-Zeybek AC, Onal H, Kiykim E, Aydin A. 2014. Differences in the gut microbiota of healthy children and those with type 1 diabetes. Pediatr Int 56:336-343, doi:10.1111/ped.12243
121. Standaert-Vitse A, Sendid B, Joossens M, François N, Vandewalle-El Khoury P, Branche J, van Kruiningen H, Jouault T, Rutgeerts P, Gower-Rousseau C, Libersa C, Neut C, Broly F, Chamaillard M, Vermeire S, Poulain D, Colombel JF. 2009. Candida albicans colonization and ASCA in familial Crohn's disease. Am J Gastroenterol 104:1745-1753, doi:10.1038/ajg.2009.225
122. Stewart CJ, Nelson A, Scribbins D, Marrs ECL, Lanyon C, Perry JD, Embleton ND, Cummings SP, Berrington JE. 2013. Bacterial and fungal viability in the preterm gut: NEC and sepsis. Arch Dis Child Fetal Neonatal Ed 98: F298-F303, doi:10.1136/archdischild-2012-302119
123. Suharja AAS, Henriksson A, Liu SQ. 2014. Impact of Saccharomyces cerevisiae on viability of probiotic Lactobacillus rhamnosus in fermented milk under ambient conditions. J Food Process Preserv 38:326-337, doi: 10.1111/j.1745-4549.2012.00780.x
124. Suhr MJ. 2015. Characterization and investigation of fungi inhabiting the gastrointestinal tract of healthy and diseased humans (master's thesis). University of Nebraska-Lincoln Press. 164 p.
125. Szabo EK, MacCallum DM. 2011. The contribution of mouse models to our understanding of systemic candidiasis. FEMS Microbiol Lett 320:1-8, doi: 10.1111/j.1574-6968.2011.02262.x
126. Tang J, Iliev ID, Brown J, Underhill DM, Funari VA. 2015. Mycobiome: approaches to analysis of intestinal fungi. J Immunol Methods 421:112-121, doi:10.1016/j.jim. 2015.04.004
127. Taylor GR, Henney MR, Ellis WL. 1973. Changes in the fungal autoflora of Apollo astronauts. Appl Microbiol 26:804-813.
128. Taylor GR, Kropp KD, Molina TC. 1985. Nine-year microflora study of an isolator-maintained immunodeficient child. Appl Env Microbiol 50:1349-1356.
129. Taylor PR, Tsoni SV, Willment JA, Dennehy KM, Rosas M, Findon H, Haynes K, Steele C, Botto M, Gordon S, Brown GD. 2007. Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nat Immunol 8:31-38, doi:10.1038/ni1408
130. Trick WE, Fridkin SK, Edwards JR, Hajjeh RA, Gaynes RP. 2002. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis 35:627-630, doi:10. 1086/342300
131. Trinci APJ, Davies DR, Gull K, Lawrence MI, Nielsen BB, Rickers A, Theodorou MK. 1994. Anaerobic fungi in herbivorous animals. Mycol Res 98:129-152, doi:10. 1016/S0953-7562(09)80178-0
132. Truss CO. 1981. The role of Candida albicans in human illness. Orthomol Psychiatry 10:228-238.
133. Ukhanova M, Wang X, Baer DJ, Novotny JA, Fredborg M, Mai V. 2014. Effects of almond and pistachio consumption on gut microbiota composition in a randomized cross-over human feeding study. Br J Nutr 111:2146-2152, doi:10.1017/S0007114514000385
134. Underhill DM, Iliev ID. 2014. The mycobiota: interactions between commensal fungi and the host immune system. Nat Rev Immunol 14:405-416, doi:10.1038/nri3684
135. van der Velden WJFM, Netea MG, de Haan AFJ, Huls GA, Donnelly JP, Blijlevens NM. 2013. Role of the mycobiome in human acute graft-versus-host disease. Biol Blood Marrow Transplant 19:329-332, doi:10.1016/j. bbmt.2012.11.008
136. van Woerden HC, Gregory C, Brown R, Marchesi JR, Hoogendoorn B, Matthews IP. 2013. Differences in fungi present in induced sputum samples from asthma patients and non-atopic controls: a community based case control study. BMC Infect Dis 13:69, doi:10.1186/1471-2334-13-69
137. von Rosenvinge EC, Song Y, White JR, Maddox C, Blanchard T, FrickeWF. 2013. Immune status, antibioticmedication and pH are associated with changes in the stomach fluidmicrobiota. ISME J 7:1354-1366, doi:10.1038/ismej.2013.33
138. Wagner RD, Pierson C, Warner T, Dohnalek M, Hilty M, Balish E. 2000. Probiotic effects of feeding heat-killed Lactobacillus acidophilus and Lactobacillus casei to Candida albicans-colonized immunodeficient mice. J Food Prot 63:638-644.
139. Walter J, Ley R. 2011. The human gut microbiome: ecology and recent evolutionary changes. Ann Rev Microbiol 65:411-429, doi:10.1146/annurev-micro-090110-102830
140. Wang ZK, Yang YS, Stefka AT, Sun G, Peng LH. 2014. Review article: fungal microbiota and digestive diseases. Aliment Pharmacol Ther 39:751-766, doi:10.1111/apt.12665
141. Weiler F, Schmitt MJ. 2003. Zygocin, a secreted antifungal toxin of the yeast Zygosaccharomyces bailii, and its effect on sensitive fungal cells. FEMS Yeast Res 3:69-76, doi:10.1016/S1567-1356(02)00126-5
142. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. 1989. Risk factors for hospital-acquired candidemia. a matched case-control study. Arch Intern Med 149:2349-2s353, doi:10.1016/0196-6553(90)90241-J
143. Whitman WB, Coleman DC, Wiebe WJ. 1998. Prokaryotes: the unseen majority. Proc Natl Acad Sci U S A 95:6578-6583, doi:10.1073/pnas.95.12.6578
144. Woyke T, Teeling H, Ivanova NN, Huntemann M, Richter M, Gloeckner FO, Boffelli D, Anderson IJ, Barry KW, Shapiro HJ, Szeto E, Kyrpides NC, Mussmann M, Armann R, Bergin C, Ruehland C, Rubin EM, Dubilier N. 2006. Symbiosis insights through metagenomic analysis of a microbial consortium. Nature 443:950-955, doi:10. 1038/nature05192
145. Xu J, Gordon JI. 2003. Honor thy symbionts. Proc Natl Acad Sci U S A 100:10452-10459, doi:10.1073/pnas.1734063100
146. Zanello G, Meurens F, Berri M, Salmon H. 2009. Saccharomyces boulardii effects on gastrointestinal diseases. Curr Issues Mol Biol 11:47-58.
147. Zaoutis TE, Prasad PA, Localio AR, Coffin SE Bell LM, Walsh TJ, Gross R. 2010. Risk factors and predictors for candidemia in pediatric intensive care unit patients: implications for prevention. Clin Infect Dis 51:e38-e45, doi:10. 1086/655698
148. Zwolińska-Wcislo M, Brzozowski T, Mach T, Budak A, Trojanowska D, Konturek PC, Pajdo R, Drozdowicz D, Kwiecien S. 2006. Are probiotics effective in the treatment of fungal colonization of the gastrointestinal tract? Experimental and clinical studies. J Physiol Pharmacol 57(Suppl 9):35-49.